Gossamer Bio (GOSS) EBIT Margin (2024 - 2026)
Gossamer Bio (GOSS) posted quarterly EBIT Margin of 264.62% for Q1 2026, up 10761.0% year-over-year from N/an in Q1 2025, and up 20.69% quarter-over-quarter from 333.64% in Q4 2025.
Gossamer Bio (GOSS) EBIT Margin (2024 - 2026) Analysis & Trends
Gossamer Bio's EBIT Margin history runs 3 years deep, the most recent figure standing at 264.62% for Q1 2026.
- In Q1 2026, EBIT Margin rose 10761.0% year-over-year to 264.62%; the TTM figure through Mar 2026 stood at 321.92% (down 26747.0% YoY), while the FY2025 annual figure was 352.23%, down 28616.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 264.62%, up from 333.64% in the prior quarter.
- The five-year high for EBIT Margin was 247.08% in Q4 2024, with the low at 372.23% in Q1 2025.
- The 3-year median for EBIT Margin is 335.52% (2025), against an average of 216.71%.
- The sharpest annual moves came in 2025 and 2026: EBIT Margin tumbled 58072 bps in 2025, then soared 10761 bps in 2026.
- Gossamer Bio's EBIT Margin stood at 247.08% in 2024, then sank by 235 bps to 333.64% in 2025, then advanced by 21 bps to 264.62% in 2026.
- Business Quant data shows GOSS's EBIT Margin at 264.62% in Q1 2026, 333.64% in Q4 2025, and 369.44% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Gossamer Bio | 47.81 Mn | -9.22 Mn | - | -282.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -282.25% |
| Mar 31, 2026 | -264.62% |
| Dec 31, 2025 | -333.64% |
| Sep 30, 2025 | -369.44% |
| Jun 30, 2025 | -337.41% |
| Mar 31, 2025 | -372.23% |
| Dec 31, 2024 | 247.08% |
| Sep 30, 2024 | -357.80% |
| Jun 30, 2024 | 54.35% |